Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.
about
Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infectionSimplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide LigationSingle-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based modelsAssociation between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay.Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencingMinority variants of drug-resistant HIV.Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapineOligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya.Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype CA comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer IDTransmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru.Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.Simultaneous and sensitive detection of human immunodeficiency virus type 1 (HIV) drug resistant genotypes by multiplex oligonucleotide ligation assay.Genetic Variability of HIV-1 for Drug Resistance Assay Development.Low-abundance drug-resistant HIV-1 variants: finding significance in an era of abundant diagnostic and therapeutic options.Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance.Implementation of a point mutation assay for HIV drug resistance testing in Kenya
P2860
Q28478459-CF961A6C-6BBC-43E2-99B7-8BCD248A8F9BQ28552499-9E11FD9E-677A-4BD1-B170-DEA0AA4C4670Q30858811-630FD397-2C18-4A3A-8BD3-54573EEB4EFDQ33741902-22C1C7CD-A26A-4D8A-879E-567DF0F8CD1EQ33798282-DCC1CD59-468C-4A93-A08F-18A7810C2421Q33827080-59B4CFCC-9CCD-4FC3-8CE5-A880802CDEDCQ33899918-3B0017B6-F987-40E7-892E-BAC561CDBFEBQ34047780-9B358456-AE40-49F9-9199-710501D0EE0AQ34071112-15B1B352-A6B6-4060-9518-86E637E24947Q34339340-D66D899F-CC5E-4621-8CCF-57A91D7E5935Q34572571-44D47C88-9AC6-4A82-8A89-8EDE22391438Q35032733-F2707CDB-E6C8-4436-AA5B-845EEA5DAA1CQ35187157-725C5246-85FF-4183-8357-B90828860E0BQ35632898-4D59FD43-7DFD-409D-A762-E4C0A15A7D19Q35647691-74E8A9AD-1DBC-4056-BC97-4CDA7C114777Q35862295-86FF2DE6-3606-476D-889F-D1A685149F81Q36102538-82EA7B40-397F-4400-B8CC-F0618F830749Q37003038-D91D1A6C-98B8-40D8-835D-2BFD5EA23B25Q38745545-30B53F68-47BA-46E1-84E0-A12607277C59Q42586120-9191AEFC-8769-4C1A-87B4-473966E233B8Q45326210-C967C37A-96BE-4ECB-8FB2-AF24EBCB0738Q57131360-F989A0FD-8588-4F06-A165-C539DB2F9AD5
P2860
Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Optimization of the oligonucle ...... r non-North American variants.
@en
type
label
Optimization of the oligonucle ...... r non-North American variants.
@en
prefLabel
Optimization of the oligonucle ...... r non-North American variants.
@en
P2093
P2860
P1476
Optimization of the oligonucle ...... r non-North American variants.
@en
P2093
Carolyn Willamson
Claudia Crowell
George Alemnji
Guido van der Groen
Helba Bredell
Ingrid A Beck
Ivette Lorenzana de Rivera
Lisa M Frenkel
Mini Jacob
Molefe Machaba
P2860
P304
P356
10.1097/QAI.0B013E31817ED7D7
P407
P577
2008-08-01T00:00:00Z